These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12145649)
21. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737 [TBL] [Abstract][Full Text] [Related]
22. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005). Souayah N; Nasar A; Suri MF; Qureshi AI J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016 [TBL] [Abstract][Full Text] [Related]
23. A practical approach to immunization in atopic children. Grüber C; Niggemann B Allergy; 2002 Jun; 57(6):472-9. PubMed ID: 12028111 [No Abstract] [Full Text] [Related]
24. Research priorities for the WHO Global Programme for Vaccines and Immunization. Lambert PH Dev Biol Stand; 1996; 87():45-9. PubMed ID: 8854001 [No Abstract] [Full Text] [Related]
25. Drug and vaccine development for infectious diseases: the value of priority review vouchers. Matheny J; Smith B; Courtney B; Mair M Clin Pharmacol Ther; 2009 Jun; 85(6):571-2. PubMed ID: 19451907 [No Abstract] [Full Text] [Related]
26. Strengthening the supply of routinely administered vaccines in the United States: progress and problems--2005. Klein JO; Helms CM Clin Infect Dis; 2006 Mar; 42 Suppl 3():S145-50. PubMed ID: 16447138 [No Abstract] [Full Text] [Related]
27. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention. Rodewald LE; Orenstein WA; Mason DD; Cochi SL Clin Infect Dis; 2006 Mar; 42 Suppl 3():S104-10. PubMed ID: 16447130 [TBL] [Abstract][Full Text] [Related]
28. Primary care physician perspectives on reimbursement for childhood immunizations. Freed GL; Cowan AE; Clark SJ Pediatrics; 2008 Dec; 122(6):1319-24. PubMed ID: 19047252 [TBL] [Abstract][Full Text] [Related]
30. [The use of new vaccines by a pediatrician on an individual basis]. González de Aledo Linos A An Esp Pediatr; 1998 Aug; 49(2):212-3. PubMed ID: 9773568 [No Abstract] [Full Text] [Related]
31. The history of vaccines and immunization: familiar patterns, new challenges. Stern AM; Markel H Health Aff (Millwood); 2005; 24(3):611-21. PubMed ID: 15886151 [TBL] [Abstract][Full Text] [Related]
32. [What vaccination has brought]. Bégué P Rev Prat; 2004 Mar; 54(5):482-8. PubMed ID: 15176504 [TBL] [Abstract][Full Text] [Related]
33. Vaccine supply and quality. Surveillance of adverse events following immunization. Wkly Epidemiol Rec; 1996 Aug; 71(32):237-42. PubMed ID: 8924387 [No Abstract] [Full Text] [Related]
35. The United States pediatric vaccine stockpile program. Lane KS; Chu SY; Santoli JM Clin Infect Dis; 2006 Mar; 42 Suppl 3():S125-9. PubMed ID: 16447134 [TBL] [Abstract][Full Text] [Related]
36. The value of immunization for God's people. Grabenstein JD Natl Cathol Bioeth Q; 2006; 6(3):433-42. PubMed ID: 17091550 [No Abstract] [Full Text] [Related]
37. Oral vaccines: new needs, new possibilities. Aziz MA; Midha S; Waheed SM; Bhatnagar R Bioessays; 2007 Jun; 29(6):591-604. PubMed ID: 17508389 [TBL] [Abstract][Full Text] [Related]
38. Financing vaccines: in search of solutions that work. Iglehart JK Health Aff (Millwood); 2005; 24(3):594-5. PubMed ID: 15886147 [No Abstract] [Full Text] [Related]
39. Immunisation. Myths and misconceptions. Robinson P; Flood M; Spicer M Aust Nurs J; 1997 Apr; 4(9):16-7. PubMed ID: 9304887 [No Abstract] [Full Text] [Related]
40. Vaccine adverse event reporting: the importance of follow-up. Varricchio F Expert Rev Vaccines; 2005 Aug; 4(4):445-8. PubMed ID: 16117700 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]